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ScienceDirectTrinucleotide repeats (TNRs) expansion disorders are severe
neurodegenerative and neuromuscular disorders that arise
from inheriting a long tract (30–50 copies) of a trinucleotide unit
within or near an expressed gene (Figure 1a). The mutation is
referred to as ‘trinucleotide expansion’ since the number of
triplet units in a mutated gene is greater than the number found
in the normal gene. Expansion becomes obvious once the
number of repeating units passes a critical threshold length, but
what happens at the threshold to render the repeating tract
unstable? Here we discuss DNA-dependent and RNA-
dependent models by which a particular DNA length permits a
rapid transition to an unstable state.
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Trinucleotide expansion is the underlying basis for dis-
ease toxicity in a number of severe hereditary diseases
[1,2,3], and occurs both in the germ line and in somatic
tissues with age. The general steps of expansion in simple
terms are three: structure formation, heteroduplex resol-
ution, and gap filling synthesis (Figure 1b). Over the past
years, many reviews (including our own) have focused on
the first step: how heteroduplex DNA structures form
[1,4,5,6] (Figure 1c). Indeed, all data are consistent
with a model in which heteroduplex structures are the
basis for expansion, which arises broadly from classes of de
novo excision repair, replication errors, and replication
arrest and restart [1,4,5,6]. All of these mechanisms
invoke their own machinery to carry out heteroduplex
resolution, and distinct polymerases to complete gap-
filling synthesis (Table 1). DNA expansion itself appears
to be independent of position of the repeat tract, otherwww.sciencedirect.com than that it must reside in or around genes to cause
observable abnormalities (Figure 1). But how do expan-
sions begin? Here, we will consider one of the oldest
questions and most puzzling feature of expansion: its
length threshold.
What is an expansion threshold? Expansion observed in
all TNR diseases requires a pre-existing long tract of
TNRs units before there is a significant probability of
instability (Figure 1a). Normal allele lengths are stable,
and there is no ‘jumping’ from a normal to a disease tract
length [7,8] (Figure 1a). Only when an allele is of critical
copy number (the threshold) does expansion become
probable within the lifetime of a human, and modulate
a transition from pre-mutation to full-mutation length
TNR tract [7–10]. The fact that expansion becomes
probable only after a threshold length is reached suggests
that expansion is strongly DNA-dependent, but why
does tract length matter? In this review, we discuss three
major models that provide possible explanations for a
length threshold in light of recent findings: firstly length-
dependent reannealing of DNA or DNA–RNA hybrids,
secondly coding for a minimum length of RNA and
protein sufficient to induce toxicity, and finally metab-
olism. These mechanisms are not mutually exclusive,
but some are more likely than others.
Does the stability and size of heteroduplex
loops in DNA govern the threshold?
One of the oldest and perhaps most intuitive explanation
for a threshold is a minimal length at which a heteroduplex
DNA intermediate becomes stable [1,2,3,4,5,6].
Indeed, we demonstrated as early as 1995 that triplet
repeats formed hairpins with repeating units of two CG
pairs and a mismatch, which explained their aberrant
migration on gels [11]. At the same time, Wells and
co-workers observed that instability occurred in bacteria
by slippage [12]. However, a structural stability model for
threshold is not entirely satisfying. Loop sizes of only a few
repeats are thermodynamically stable in replication slip-
page reactions [6], and the MutL endonuclease that
resolves small loops in DNA operates efficiently at 1–4
contiguous triplet units [13].
However, the sizes of the heteroduplex loops that occur
during repair are expected to be larger. The excision
patch of transcription coupled repair (TCR) and nucleo-
tide excision repair (NER) is typically around 15–20 bases
[14], corresponding to a fold-back structure of 5–7
repeats. Strand displacement during long patch BER isCurrent Opinion in Genetics & Development 2014, 26:131–140
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H-DNA
Features of expansion and its threshold. (a) Generic representation of
threshold limits for some representative disease alleles from distinct
TNR disorders. The inverted purple triangles represent the size ranges
associated with the normal, threshold, and disease length TNR alleles. In
white is the threshold length for representative TNRs: CGG in the 50-
untranslated (50UT) region characterizes the FMR-1 gene; GAA in an
intron (lines) characterizes Friedreich’s ataxia gene; CAG in a coding
region (exon) characterizes the Huntington’s gene; CTG in the 30-
untranslated (30UT) region characterizes the myotonic dystrophy 1 (DM1)
gene. The threshold limit is also referred to as the premutation length, as
all full mutations arise from lengths at the upper range of normal allele
and the lower edge of disease allele lengths. Below that range are stable
normal repeats, and above the ranges at which expansion exists. The
premutation lengths as shown are approximate sizes since there is no
precise range THD is threshold. (b) The three most basic steps of
expansion. (c) Distinct types of heteroduplex DNA loops are proposed
as precursors to expansion: hairpins (1); cruciform (2); quadraplex (3);
H-DNA triplet helix (4).
(c) is taken from [5].around the same size or larger when CAG TNRs are the
repair substrate [15,16]. Moreover, small chemical
lesions such as 8-oxo-guanine can trigger a switch to
translesion synthesis by Pol h in yeast [17]. Polymerase
pausing is noted in long non-coding TNRs, and the size of
the loops formed during fork reversal [18] or strand-
switching [19] mechanisms have the potential to promote
even larger loops. The endonucleases (Table 1) that
resolve the larger loops and their integration into genomic
DNA are, as yet, unknown [20,21,22,23–36,37,38].
A kinetic model for the threshold on the DNA level is more
likely. At any single strand break or on Okazaki fragments,
free ends are in flux on and off DNA, and there is inherent
competition between duplex reformation (no mutation)
and structure formation at the frayed end (mutation inter-
mediate). The threshold transition length may simply
reflect the length at which the lifetime of self-pairing inCurrent Opinion in Genetics & Development 2014, 26:131–140 heteroduplex DNA becomes long enough to exceed the
rate of gap filling synthesis (which would prevent duplex
reannealing). The resulting flap folds-back to initiate
structure formation at the TNR sequence. Indeed, we
tested at least part of this idea by following duplex rean-
nealing of complementary hairpins of 10 (lower than
threshold) and 25 CAG repeats (at the threshold) [39].
The rate of duplex reannealing for the 25 units was one to
six fold slower than the 10 units CAG repeat hairpin,
although they were of similar stability. The hairpin struc-
ture of 25 units re-formed duplexes reannealed roughly 50-
fold slower relative to unstructured random sequences,
unstructured scrambled CAG nucleotides, and dinucleo-
tide repeating sequences of identical length [39]. Many
more constraints occur in vivo, and whether the lifetime of
long flaps exceeds the rate of gap filling synthesis in vitro or
in vivo remains to be measured. Nonetheless, the kinetic
lifetime of the fold-back structure distinguishes a CAG/
CTG tract at the threshold from shorter CAG/CTG tracts
by the reannealing rate.
The role of RNA–DNA hybridization in
determining the threshold
But could RNA determine the DNA threshold for expan-
sion? Reannealing kinetics appears to be relevant for a
TNR threshold mechanism that is R-loop dependent
[40,41]. RNA–DNA hybrids form at the expanded
(n > 200 rpts) but not normal CGG repeat regions (com-
monly 30 rpts) in the FMR1 gene from human iPSCs that
were differentiated in culture for 30–60 days [40]. The
majority of the RNADNA duplex occurs between 200 and
300 bp on either side of the expanded CGG tract, consist-
ent with the notion that the promoter harboring the tran-
scribed CGG-repeat tract is the binding site for the FMR1
mRNA. Transcription through the GC-rich FMR1 50UTR
region favors R-loop formation, with the nascent (G-rich)
RNA forming a stable RNA:DNA hybrid with the template
DNA strand (Figure 2a,b), thereby displacing the DNA
strand. Recruitment of the TCR machinery at the stalled
site may promote nicking and expansion at the site for
repair during removal of the RNA–DNA hybrid block
(Figure 2c). In the iPSC system, binding of the FMR1
mRNA to the genomic repeat does not occur before day 45,
implying that the hybrid forms slowly [40]. Thus, the size
of a stable hybrid might determine the length at which an
open transcription bubble ‘sensitizes’ the TNR sensitive to
damage (Figure 2a) and render it subject to TCR or BER
(Figure 2c). Alternatively, the RNA–DNA bubble may be
the threshold ‘impediment’ needed for ‘calling in’
fork reversal [18] or strand-switching [19] resolution
mechanisms.
Because of patient variability, it is difficult to determine
the precise relationship among transcriptional silencing,
the size of the RNA–DNA hybrid, or the level of chemi-
cally modified bases. Missing from the iPSC experiments
are robust measures of the DNA methylation status andwww.sciencedirect.com
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Table 1
Mammalian structure-specific endonucleases
Molecule Loop size
(n = # rpts)
Pathway Refs Endonuclease function
MutL n < 4 rpts MMR [21] Removal of mismatches and small loops
MRE11 n.d. DSBR [22,23] 30–50 endonuclease activity at DSBs; hairpin cleaving activity
MRE11/Sae2 Hairpin cleaving activity with a single strand nick
APE n > 4 rpts BER [24] Cleaves 50 side of abasic site generating a 30-OH group for
polymerase extension
XPF/ERCC1 n > 4 rpts NER/TCR [25,26] Cleaves a 50 bubble substrates
XPG n > 4 rpts NER/TCR [26] Cleaves a 30 bubble substrates
Mus81/Eme1 n.d. DSBR [27] Structure-specific 30-flap DNA endonuclease that can
process substrates resembling replication intermediates
SLX n.d. DSBR [28,29] Endonuclease activity toward replication forks, 50-flaps, and
Holliday junctions
FEN-1 Replication/gap
filling repair
[30] Member of the XPG/RAD2 endonuclease family. Removes 50
overhanging flaps in DNA repair; processes the 50 ends of
Okazaki fragments in lagging strand DNA synthesis; cofactor
in gap filling repair-dependent replication DNA secondary
structure can inhibit FEN-1 flap processing
Gen1/YEN1 n.d. DSBR, HR [31] Holliday junction 50 flap endonuclease and resolves Holliday
junctions
ZRANB3 n.d. Replication stress [32,33] Localizes to DNA replication sites and interacts with the
components of the replication machinery. Maintains genome
stability at stalled or collapsed replication forks by facilitating
fork restart and limiting inappropriate recombination that
could occur during template switching events; acts as a
structure-specific endonuclease that cleaves the replication
fork D-loop intermediate, generating an accessible 30-OH
group in the template of the leading strand. Cleaves
branched DNA structures with unusual polarity
GQN1 n.d. Somatic hypermutability [34] (G quartet nuclease 1) cleaves within the single-stranded
region 50 of the barrel formed by stacked G quartets. GQN1
does not cleave duplex or single-stranded DNA, Holliday
junctions, or G4 RNA
SNM1 n.d. ICL [35] Operates predominantly in interstrand crosslink (ICL) repair;
structure-specific DNA hairpin opening endonuclease
RNase H n.d. RNA/DNA duplexes [36] RNase H is a ribonuclease that cleaves the RNA in a DNA/
RNA duplex to produce ssDNA. RNase H is a non-specific
endonuclease and catalyzes the cleavage of RNA via a
hydrolytic mechanism, aided by an enzyme-bound divalent
metal ion. RNase H leaves a 50-phosphorylated product
Dicer RNA Double stranded RNA [37] Dicer is an endoribonuclease in the RNase III family that
cleaves double-stranded RNA (dsRNA)
Cas9 breaks RNA DNA/RNA [38] RNA-guided DNA endonuclease to generate double-strand
DNA editingalterations of the CGG tract length that might have
occurred during a 30–60 day differentiation period [40].
Extensive methylation in the promoter region at CGG
repeats accompanies transcriptional suppression [42]. If
the RNA–DNA hybrid triggers methylation and hetero-
chromatin formation, then another attractive model for
expansion is the removal of methylated bases and DNA
loop formation via BER [43]. Although removal of meth-
ylated bases by BER is accomplished by several DNA
glycosylases with different specificities, none are known
to promote TNR expansion. In fact, expansion is likely to
occur in unmethylated state: (1) Rare individuals having
full mutations but normal intelligence lack hypermethy-
lation and maintain expression of FMR1 mRNA [44]. (2)
Pharmacologic treatment with the DNA methylationwww.sciencedirect.com inhibitor 5-aza-20-deoxycytidine (azadC) reactivates tran-
scription and FMRP expression but does not alter the
repeat tract [45]. More likely, expansion is a response to
the stress of RNA-induced or protein-induced aggrega-
tion/toxicity, which enhances oxidative damage in DNA.
Removal of the oxidized bases by the BER or TCR
pathways results in loop formation and expansion.
Indeed, loss of OGG1 [15], NEILS 1 [46], and XPA
[47] reduces expansion in mice. Novel mechanisms for
enhancing oxidative damage and toxicity are discussed
below.
Whether RNA–DNA hybrids form at TNRs in other non-
coding regions (which generate large expansions) is
unknown. In coding regions, the expanded CAG/CTGCurrent Opinion in Genetics & Development 2014, 26:131–140
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(a) A schematic representation of an RNA–DNA hybrid and its role in hypothetical mechanisms in TNR expansion during transcription. (a) In the FMR1
gene, the RNA–DNA hybrid is proposed to form at the promoter region including the 50 untranslated region harboring CGG repeat. The paused RNA
polymerase stabilizes the open transcription bubble, which is susceptible to oxidative DNA damage. A possible model for expansion is oxidative stress
and base damage which is removed during BER [2,15]. (b) A possible model for TNR deletion at the RNA–DNA hybrid site. The open non-
transcribed strand forms self-paired DNA loops along the transcription bubble as polymerase passes [2,5]. (c) TCR may also play a role by
removing the RNA–DNA hybrid. At or below the threshold, the stalled polymerase may successfully recruit the TCR machinery or utilize it in some way
to remove the RNA–DNA hybrid. If XPG is inhibited, a flap structure folds-back to form a structural intermediated for expansion. These loops are most
likely to result in deletion after subsequent removal, although expansion is possible if an endonuclease is able to clip the hairpin loops on the unpaired
DNA strand, and the TNR duplex is restored by gap filling synthesis [2,5].repeat tracts (n > 35 rpts) overlap in length with those of
the FMR-1 ‘normal’ CGG range [1,2,3,4,5,6]
(commonly 30 rpts), which does not form hybrids. More-
over, CAG expansions do not impose transcription
silencing of their respective genes [1,3]. If a minimum
DNA–RNA hybrid causes the transcriptional silencing at
a threshold length, then it is unlikely to be a mechanism
that is common to all TNR genes.
Double stranded RNA models for expansion.
Another consideration in a RNA-dependent hybridization
model for threshold is the effect, if any, of bi-directional
transcription of the TNR region [48]. For example,
several novel anti-sense FRM1 transcripts exist in the
FRM1 locus (ASFMR4-6), and some overlap the CGG
repeat region [49]. ASFMR4 transcript is spliced, poly-
adenylated and exported to the cytoplasm [42,49]. If a bi-
directional transcript overlaps with the sense transcript,
double stranded RNA is formed as a Dicer substrate. It is
not easy to imagine how short siRNA hybrids within theCurrent Opinion in Genetics & Development 2014, 26:131–140 TNR tract results directly in expansion. Either multiple
siRNA binding creates a RNA–DNA hybrid of similar
length to that of an mRNA hybrids [40], and are removed
by similar mechanisms, or the shorter RNA–DNA hybrid
opens the DNA sufficiently to increase exposure to
oxidative DNA damage at a preferred threshold length
(Figure 2a).
Protein–RNA interaction models for the
threshold
New models provide insight on how RNA–protein com-
plexes of threshold length might provoke chemical
lesions in DNA, and lead to expansion. TAR-DNA-bind-
ing protein 43 (TDP-43) [50] is poised to bind to a RNA–
DNA hybrid. TDP-43 is a dimeric protein with two RNA
recognition motif (RRM) domains that bind both DNA
and RNA [50,51,52] (Figure 3a–c), and interact with
fragile X mental retardation protein (FMRP) in an
(FMRP)/Staufen (STAU1) complex [53]. This complex
forms aggregates analogous to those of polyglutaminewww.sciencedirect.com
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The structural models of TDP-43 and MBNL bound to nucleic acids are similar. (a) TDP-43 binds to both DNA and to RNA. The small angle X-ray
scattering (SAXS) envelope of TDP-43 dimer is fitted with the crystal structure of RNA recognition motif (hRRM1)-DNA and mRRM2-DNA in the
orientation that the DNA forms a continuous 50–30 strand, as it is bound from hRRM1 to mRRM2 in TDP-43. (b) SAX structure of a TDP-43 monomer
bound to ssDNA. The putative RNA binding sequence of TDP-43 is derived from the sequence of two tandem RNA recognition motifs (RRM), hRRM1-
DNA and mRRM2-DNA complexes. The RRMs in TDP-43 dimers participate in binding of UG-rich RNA or TG-rich DNA with RRM1 playing a dominant
role and RRM2 playing a supporting role. The RRM1 binds to RNA with extensive contacts with the conserved b-sheet residues and loop residues. (c)
Schematic representation of the domains structure of TDP-43 homodimer, which binds to a long UG-rich RNA via its RRM1 and RRM2 domains. (d)
Ribbon diagram presentation of zinc finger domain of MBNL2, with the side chains of the ligand residues and zinc ions (Gray balls) and binds to a GU-
rich sequence (e). (f) Like TDP-43, MBNL2 is also capable of forming a dimer. Each circle represents a CCCH-type zinc finger motif, and the black
arrows represent the zinc finger orientation corresponding to the direction of the first helix in each of the domains. The red arrows indicate the 50–30
direction of the two accommodated RNA on the TZF12 of the MBNL2 dimer.proteins, which induce cellular stress and oxidative DNA
damage. The DNA length at which the encoded RNA
forms aberrant protein–RNA complexes may be the
threshold for the enhanced stress.
The mechanisms of RNA aggregate formation are
unknown, but it is likely due to the disruption of complex
formation at its C-terminus. TDP-43 interacts at its
C-terminus with the hnRNP family of translation factors,
as well as the splicing factors muscleblind (MBNL) and
CUG-BP1 (CUG binding protein 1) [54]. MBNL and
CUG-BP1 impart two opposing effects on splicing,
and they occur through binding of distinct regions of
the target RNA [55]. Both CUG-BP1 and MBNL bind
to short-structured CUG and CCUG repeats in RNA with
high affinity and specificity [55] (Figure 3d,e). Only 6 base
pairs are necessary for MBNL binding: two pyrimidine
mismatches and four guanosine–cytosine base pairs that
form in a helical region of a stem-loop in the endogenous
pre-mRNA target [55] (Figure 3e). In the myotonicwww.sciencedirect.com dystrophy gene (DM1), these two regions of the RNA
reside on the 30 and 50 sides that surround the TNR [56].
The length of the TNR tract affects only MBNL binding
and impairs its function. A loss-of-function in MBNL
and a gain-of-function in CELF4 tend to favor generation
of the alternatively spliced forms.
TDP-43 also binds to both the 30 and 50 end of the DM1
mRNA, and raises the possibility of that binding of
MBNL and TDP-43 occurs at the same sites. Whether
these two proteins overlap in the recognition to mRNA is
unknown, but the common binding sites and function-
ality in the DM1 mRNA raise the possibility that the
bi-partite mRNA binding at the C-terminus of TDP-43
integrates translation and splicing activity. Interestingly,
TDP-43 controls its own expression through a negative
feedback loop involving interactions with its mRNA at
the 30 end [57]. Furthermore, the domain structure of
TDP-43 is similar to that of both heterogeneous nuclear
ribonucleoprotein (hnRNP) and muscleblind (MBNL)Current Opinion in Genetics & Development 2014, 26:131–140
136 Molecular and genetic bases of disease[58] (Figure 3f): an N-terminal domain (NTD) and two
tandem RNA recognition motifs (RRM1 and RRM2),
followed by a C-terminal glycine-rich region (G)
(Figure 3a–c). The C-terminus of TDP-43 acts as a
hub that regulates both splicing and translation. Indeed,
TNR coding transcripts are associated with an unusual
type of translation, Repeat Associated Non-ATG trans-
lation (RAN-translation) [59]. RAN-translation does not
require an ATG translation start site, and random trans-
lation at TNRs occurs in all reading frames [59].
Given its hub-like features, maintaining the C-terminus of
TDP-43 would appear to be a key regulatory process.
Indeed, pathological TDP-43 in the cytoplasmic and intra-
nuclear inclusions is hyper-phosphorylated, ubiquitinated,
and cleaved to 25 kDa C-terminal fragments in affected
brain regions [60]. C-terminal-deleted TDP-43 without
the glycine-rich tail is sufficient to form a head-to-head
homodimer primarily via its N-terminal domain, which
form fibrils in vitro [60]. Thus, proteolytic cleavage of
TDP-43 within the RRM2 removes the N-terminal dimer-
ization domain and produces unassembled truncated
RRM2 fragments, which can abnormally oligomerize intoFigure 4
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Current Opinion in Genetics & Development 2014, 26:131–140 high-order inclusions (Figure 3). The resulting increase in
oxidative DNA damage promotes expansion indirectly by
RNA-mediated depletion of TDP-43/FMRP/STAU1 in
the nucleus and an increase in cellular stress.
The role of maintaining balanced DNA
methylation in expansion
Whether this type of RNA-mediated mechanism applies
to all triplet repeat disorders is unknown, but there are
direct links between them and mitochondrial metab-
olism. A TDP-43 binds to the mRNA of the silent
information regulator 1 (SIRT1), which is implicated in
double-stranded DNA break repair and DNA metabolism
in all cells [61]. SIRT1 is an NAD+ dependent class III
histone deacetylase [61], which cooperates with
elongation factor 1 (E2F1) to regulate apoptotic response
to DNA damage. SIRT1 knockdown results in poly
Q-expanded aggregation of androgen receptor (AR) and
a-synuclein [62], consistent with a role of the
SIRT1mRNA-TDP-43 complex in aggregation, and sup-
ports the notion that RNA processing by TDP-43 and
chromatin organization SIRT1 are functionally con-
nected. TDP-43 regulates alternate splicing of the CFTRMe
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) is a critical co-factor for the ten-eleven translocation dioxygenase (TET)
ylation, and EGLN1 gene product, hypoxia-inducible factor prolyl
HD2), is an enzyme encoded by the EGLN1 gene. It is also known as Egl
egradation pathway by hydroxylation of proline-564 and proline-402 by
thytransferases (DNMTs) converts cytosine (C) for 50 methyl C. The TET
roxylmethyC is removed by the BER enzyme, TDG, to restore C, which is
 to restore C, which is subsequently methylated. Success of this cycle
the removal of 5-hydrolymethylcytosine and restoration to cytosine to re-
www.sciencedirect.com
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Two-state threshold model. (a) The binding pocket of the OH-CH3-cytosine in TDG. (b) The overall cartoon structure of the OH-CH3-cytosine-TDG
complex. (c) The toxic oxidation cycle. We propose a two-state model for expansion. Expansion arises from toxicity imparted from RNA and protein-
mediated toxicity by two mechanisms. RNA and protein-mediated toxicity induces mitochondrial stress and a concomitant increase in oxidative
damage to DNA. The oxidative damage is removed by DNA glycolsylases. 8-oxo-guanine glycolsylase (OGG1)* is a major enzyme that removes
oxidative damage, but it can also be removed by the NEILS 1* glycosylase, or the machinery of TCR*. Single strand break intermediates arise during
base removal and produce flaps that fold-back to generate structural intermediates for expansion.RNA at the intron8/exon9 junction, implying that alterna-
tive splicing may have a direct consequence on the
chromatin organization, which is altered at long, conge-
nital TNR lengths.
Interestingly, isocitrate dehydrogenase 1 (IDH1) and
IDH2 catalyze the interconversion of isocitrate and a-
ketoglutarate (a-KG) [63] (Figure 4a). a-KG is a TCA
cycle intermediate in mitochondria, and is an essential
co-factor for many enzymes, including JmjC domain-
containing histone demethylases [63,64], and a family
of 5-methlycytosine (5mC) hydroxylases, Ten-eleven
translocation dioxygenase (TET) [64] and EglN pro-
lyl-4-hydroxylases (Figure 4a). Both TET1 and TET3
proteins contain a DNA-binding motif that is believed to
target CpG sites (Figure 4a). TET2 converts 5-methyl-
cytosine to 5-hydroxymethylcytosine (5-hmC) in DNA
and uses a-ketoglutarate as a co-substrate [65]. The
resulting (5-hmC) is removed by the BER enzymewww.sciencedirect.com thymine DNA glycosylase (TDG) [64] (Figure 4b).
At the excision site, cytosine replaces 5-hmC, and meth-
ylation occurs subsequently to restore the methylated
state and 5-mC [64] (Figures 4b and 5a,b). Thus,
metabolism is apparently a regulatory mechanism to
maintain a balanced methylaytion state, and influences
expansion. Since methylation status does not appear to
play a role in expansion per se, RNA-induced and protein-
induced toxicity may act in a feed-back loop, producing a
toxic oxidation cycle and expansion during removal of the
oxidative DNA damage (Figure 5c).
Conclusions
Although new possibilities for DNA-mediated, RNA-
mediated and protein-mediated toxicity are emerging,
these diverse pathways, in the end, are likely to induce
expansion by similar mechanisms (Figure 5). Physically,
expansion occurs by loop formation at free DNA ends
during DNA excision, by polymerase slippage or byCurrent Opinion in Genetics & Development 2014, 26:131–140
138 Molecular and genetic bases of diseasestrand switching events that occur during replication or
fork-reversal. From this simple viewpoint, we can con-
struct both physical and functional definitions of an
expansion threshold. Physically, the threshold defines a
kinetic point in which self-pairing ‘wins’ over duplex
reformation. Structures form at Okazaki fragment ends
and/or at single strand breaks are trapped by gap filling
synthesis or continued replication (Figure 5). Function-
ally, the threshold is likely to be the limiting length at
which lesion load induces DNA repair.
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